Kalvista Pharmaceuticals Inc (KALV) Insider Trading
- $47,177,663.82
- $70,138,694.58
- March 7, 2025
- Thomas Andrew Crockett
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| Jan. 25, 2019 | Insider | 5,453 | $17.06 | Sell | $93,028.18 | |
| Jan. 23, 2019 | Insider | 1,902 | $17.01 | Sell | $32,353.02 | |
| Jan. 16, 2019 | Insider | 4,000 | $19.55 | Sell | $78,200.00 | |
| Jan. 14, 2019 | CEO | 10,000 | $19.33 | Sell | $193,300.00 | |
| Jan. 7, 2019 | Major Shareholder | 4,299 | $20.25 | Sell | $87,054.75 | |
| Jan. 2, 2019 | Major Shareholder | 200 | $20.00 | Sell | $4,000.00 | |
| Dec. 31, 2018 | Major Shareholder | 25,418 | $20.00 | Sell | $508,360.00 | |
| Dec. 28, 2018 | Major Shareholder | 3,734 | $20.03 | Sell | $74,792.02 | |
| Dec. 19, 2018 | Major Shareholder | 2,136 | $20.02 | Sell | $42,762.72 | |
| Sept. 10, 2018 | Director | 1,058,824 | $17.00 | Buy | $18,000,008.00 | |
| Oct. 12, 2017 | Major Shareholder | 2,725,283 | $9.64 | Sell | $26,271,728.12 | |
| Oct. 12, 2017 | Director | 850,000 | $8.50 | Buy | $7,225,000.00 | |
| Sept. 15, 2017 | Major Shareholder | 176,647 | $7.21 | Sell | $1,273,624.87 | |
| Sept. 14, 2017 | Major Shareholder | 10,000 | $8.05 | Sell | $80,500.00 | |
| Sept. 13, 2017 | Major Shareholder | 25,900 | $8.02 | Sell | $207,718.00 | |
| Dec. 30, 2015 | CEO | 10,000 | $3.70 | Sell | $37,000.00 | |
| April 14, 2015 | Major Shareholder | 877,500 | $5.00 | Buy | $4,387,500.00 | |
| April 14, 2015 | Director | 1,012,500 | $5.00 | Buy | $5,062,500.00 |
Insiders are both buying and selling Kalvista Pharmaceuticals Inc stock.
The insider traders at Kalvista Pharmaceuticals Inc are: Thomas Andrew Crockett, Venrock Healthcare Capital Par, Benjamin L Palleiko, Christopher Yea, Edward P Feener, Albert Cha, Paul K Audhya, Svlsf Iv, Llc, Life Sciences Fund Iv (Gp) Sv, Holdings A/S Novo, Andreas Maetzel, Michael David Smith, Acmp Iv Llc, Rajeev M Shah, David Renzi, and Daniel B Soland
The most active insider trader at Kalvista Pharmaceuticals Inc is Thomas Andrew Crockett with 22 trades.
Holdings A/S Novo has sold the most Kalvista Pharmaceuticals Inc stock with a total value of $54,105,299.11.
Albert Cha has bought the most Kalvista Pharmaceuticals Inc stock with a total value of $29,566,911.61.
The most recent insider trade for Kalvista Pharmaceuticals Inc was on March 7, 2025.
The single biggest insider buy for Kalvista Pharmaceuticals Inc was from Albert Cha with a total value of $18,000,008.00 on Sept. 10, 2018.
The single biggest insider sell for Kalvista Pharmaceuticals Inc was from Holdings A/S Novo with a total value of $26,271,728.12 on Oct. 12, 2017.